Functional Physical Therapy

Join us at the C3 Annual Summit, June 26–28, 2026 in Denver, for an innovative, collaborative approach to restoring functional connections between the core and lower extremities.
​A Multidisciplinary Conference on Treatment Strategies for Restoring Functional Connections between the Core and the Lower Extremities

Experience 3 days of ​Interactive Lectures and Skills Lab Sessions​.

Co-directed by Gail Wetzler, PT, DPT, EDO, BI-D.

Learn more & register: https://collaborativecarecollective.com/

Agenda:
https://collaborativecarecollective.com/agenda/

Come join us for the conference and the anatomy lab on the optional day 4! So amazing to see the anatomy of what we have been studying for the conference!

Our Optional Day 4 Anatomy Lab is back by popular demand. This sold out quickly last year. Book your spot now.

https://collaborativecarecollective.com

Very interesting study!

𝗧𝗼 𝗖𝘂𝘁 𝗼𝗿 𝗡𝗼𝘁 𝘁𝗼 𝗖𝘂𝘁? 𝗥𝗲-𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗻𝗴 𝗦𝘂𝗿𝗴𝗲𝗿𝘆 𝗳𝗼𝗿 𝗗𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗲𝗻𝗶𝘀𝗰𝗮𝗹 𝗧𝗲𝗮𝗿𝘀 𝘄𝗶𝘁𝗵 𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝗰𝗮𝗹 𝗦𝘆𝗺𝗽𝘁𝗼𝗺𝘀

⬛️ For years, the management of degenerative meniscal tears has been a source of debate within the orthopaedic community.
⬛️ While evidence generally discourages arthroscopic meniscal surgery for degenerative tears, clinical guidelines have remained ambiguous regarding patients who present with mechanical symptoms—such as locking, catching, clicking, or popping of the knee.
⬛️ A new systematic review and meta-analysis published in the Journal of Orthopaedic Reports 2025 by Zilani et al. challenges the notion that mechanical symptoms justify surgical intervention, offering pivotal insights into the long-term outcomes of surgery versus non-operative management.

⚖️ 𝙏𝙝𝙚 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝘿𝙞𝙡𝙚𝙢𝙢𝙖

📌 Degenerative meniscal tears are common in older populations and are often associated with knee osteoarthritis.
📌 Current guidelines, such as those from the AAOS American Academy of Orthopaedic Surgeons, often provide unclear recommendations for tears accompanied by mechanical symptoms, leading many surgeons to view these symptoms as a valid indication for surgery.
📌 However, the efficacy of this approach has been questioned.
📌 This new review aimed to fill a critical gap in the literature by specifically analyzing 5-year outcomes in patients with degenerative tears and mechanical symptoms, comparing those who received surgery against those managed non-operatively such as physical therapy.

📊 𝙆𝙚𝙮 𝙁𝙞𝙣𝙙𝙞𝙣𝙜𝙨: 𝙁𝙪𝙣𝙘𝙩𝙞𝙤𝙣 𝙫𝙨. 𝙇𝙤𝙣𝙜-𝙏𝙚𝙧𝙢 𝙃𝙚𝙖𝙡𝙩𝙝

⬛️ The review analyzed six randomized controlled trials involving 1157 participants.
⬛️ The results highlight a distinct trade-off between subjective health perception and objective joint preservation.

✅ 𝙉𝙤 𝙎𝙞𝙜𝙣𝙞𝙛𝙞𝙘𝙖𝙣𝙩 𝘽𝙚𝙣𝙚𝙛𝙞𝙩 𝙛𝙤𝙧 𝙆𝙣𝙚𝙚 𝙁𝙪𝙣𝙘𝙩𝙞𝙤𝙣 𝙤𝙧 𝙋𝙖𝙞𝙣

⬛️ Contrary to the belief that surgery resolves mechanical dysfunction, the study found no significant difference between arthroscopic surgery and non-operative management regarding knee function, activity levels, or meniscal evaluation at the 5-year mark.
⬜ Scores for the Lysholm Knee Scoring Scale measuring limp, locking, and instability showed no statistically significant difference between the groups p = 0.07.
⬜️ Activity levels, measured by the Tegner Activity Scale, were identical between surgical and non-surgical patients p = 1.00.
⬜️ Pain scores VAS for activity and rest also showed no significant statistical difference.

⚠️ 𝙏𝙝𝙚 "𝙃𝙞𝙙𝙙𝙚𝙣" 𝘾𝙤𝙨𝙩: 𝙄𝙣𝙘𝙧𝙚𝙖𝙨𝙚𝙙 𝙊𝙨𝙩𝙚𝙤𝙖𝙧𝙩𝙝𝙧𝙞𝙩𝙞𝙨 𝙋𝙧𝙤𝙜𝙧𝙚𝙨𝙨𝙞𝙤𝙣

⬛️ Perhaps the most critical finding of this review is the long-term impact of surgery on joint health.
⬛️ Patients who underwent arthroscopic surgery demonstrated a significantly higher rate of osteoarthritis progression compared to those treated non-operatively.
⬜️ The odds ratio for radiographic osteoarthritis progression was 2.09 in the surgical group.
⬜️ This suggests that while removing torn tissue might intuitively seem helpful, the surgical intervention itself—or the resulting loss of meniscal tissue—may accelerate the degenerative process within the knee joint.

🧠 𝘼 𝙋𝙖𝙧𝙖𝙙𝙤𝙭 𝙞𝙣 𝙋𝙖𝙩𝙞𝙚𝙣𝙩 𝙋𝙚𝙧𝙘𝙚𝙥𝙩𝙞𝙤𝙣

⬛️ Interestingly, while specific knee function scores did not differ, patients in the surgical group reported significantly better general health scores on the EQ-VAS European Quality of Life Visual Analog Scale compared to the non-operative group p < 0.00001.
⬛️ This suggests that surgery may offer a psychological benefit or a perceived improvement in overall well-being that is not captured by specific knee function metrics.

🩻 𝙄𝙢𝙥𝙡𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨 𝙛𝙤𝙧 𝙏𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩

⬛️This study provides high-quality evidence suggesting that mechanical symptoms should not automatically trigger a decision to operate.

👤 For Patients
⬜️ If you have a degenerative tear with clicking or catching, physical therapy is likely to yield similar functional results to surgery over five years, without the increased risk of accelerating osteoarthritis.
👨‍⚕️ For Clinicians
⬜️ The presence of mechanical symptoms does not necessarily predict a better response to surgery.
⬜️ The "quick fix" of removing the mechanical obstruction must be weighed heavily against the doubled risk of long-term osteoarthritic changes.

🏁 𝘾𝙤𝙣𝙘𝙡𝙪𝙨𝙞𝙤𝙣

📌 The findings of Zilani et al. suggest that non-operative management should be the primary treatment pathway for degenerative meniscal tears, even when mechanical symptoms are present.
📌 While surgery may improve a patient's general perception of health, it fails to provide superior knee function and actively contributes to the worsening of osteoarthritis over time.

-----------------
⚠️Disclaimer: Sharing a study or a part of it is NOT an endorsement. Please read the original article and evaluate critically.⚠️

Link to Article 👇

Really cool study!!

💨 Everyday nasal spray shows surprising power against COVID—and more

A simple over-the-counter nasal spray, already used worldwide for allergies, may also protect against COVID-19.

In a phase 2 clinical trial led by Saarland University, Germany, researchers tested azelastine, a medication available in more than 70 countries. Over eight weeks, only 2.2% of people using the spray contracted COVID-19—compared to 6.7% in the placebo group. That’s a two-thirds reduction in cases.

Even more intriguing, azelastine also appeared to reduce symptomatic infections, respiratory illnesses, and even rhinoviruses (the common cold), hinting at broader antiviral effects. Scientists think the spray works by blocking viral replication directly in the nose and upper airways—the entry point for most respiratory pathogens.

Because it’s already approved for hay fever and allergies, azelastine could become an accessible, low-cost preventive option. While it’s not yet authorized as a COVID treatment, researchers say it may be especially useful for vulnerable individuals and during seasonal surges of respiratory infections. Larger, multicenter studies are now needed to confirm these results.

📖 Source:
Lehr T, Meiser P, Selzer D, et al. Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial. JAMA Internal Medicine, September 2, 2025.

Only 8 days away! Excited to be a part of the symposium and to see the other speakers!

https://shop.iahe.com/Workshops/Online-Learning-Programs-and-Workshops-all-Institutes/CC25-09.13-14.25-VIRTUAL?partner=85145NANCYHARRISON

CC25 Virtual Symposium – Crossroads of Collaboration: Expanding The Vision For Visceral & Manual Therapies – The Barral Institute STARTS September 13, 2025 DURATION 2 – Days Online 10 Hours total CC25 FEE Early Saver US$295 59 – 30 days before US$345 Full Price US$395 REGISTER NOW AND SAVE cc25 rEGISTRATION A Collaboration of Wisdom CC25 is more than a symposium—it’s a shared commitment to the future of manual therapy....

What a great day of education, curiosity, and friends!